| For: | Lin WT, Liao YJ, Peng YC, Chang CH, Lin CH, Yeh HZ, Chang CS. Relationship between use of selective serotonin reuptake inhibitors and irritable bowel syndrome: A population-based cohort study. World J Gastroenterol 2017; 23(19): 3513-3521 [PMID: 28596687 DOI: 10.3748/wjg.v23.i19.3513] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i19/3513.htm |
| Number | Citing Articles |
| 1 |
Tommaso B. Jannini, Giorgio D. Lorenzo, Emanuela Bianciardi, Cinzia Niolu, Massimiliano Toscano, Giacomo Ciocca, Emmanuele A. Jannini, Alberto Siracusano. Off-label Uses of Selective Serotonin Reuptake Inhibitors (SSRIs). Current Neuropharmacology 2022; 20(4) doi: 10.2174/1570159X19666210517150418
|
| 2 |
Viktoriya L. Nikolova, Lucy Pelton, Calum D. Moulton, Daniele Zorzato, Anthony J. Cleare, Allan H. Young, James M. Stone. The Prevalence and Incidence of Irritable Bowel Syndrome and Inflammatory Bowel Disease in Depression and Bipolar Disorder: A Systematic Review and Meta-Analysis. Psychosomatic Medicine 2022; 84(3) doi: 10.1097/PSY.0000000000001046
|
| 3 |
S.‐M. Hsu, H.‐J. Lin, M.‐C. Lin, S.‐T. Huang. Increased incidence and recurrence rates of acute diverticulitis in patients with irritable bowel syndrome. Colorectal Disease 2020; 22(12) doi: 10.1111/codi.15325
|
| 4 |
Heba Ahmed Abdelaziz, Walid Ismail Ellakany, Ahmed Ellakany, Yomna E. Dean, Samah S. Rouzan, Bdoor Ahmed A. Bamousa, Mohamed A. Shebl, Sameh Samir Elawady, Suman Verma, Deepak Gir, Taher Sbitli, Ibram Zaki, Lakshya Motwani, Ramy Eweis, Naila Iqbal, Jaffer Shah, Hani Aiash. The relationship between anxiety and irritable bowel syndrome symptoms among females: A cross-sectional study in Egypt. Medicine 2023; 102(32) doi: 10.1097/MD.0000000000034777
|
| 5 |
Ahmet Sahan, Alkan Cubuk, Orkunt Ozkaptan, Tuncay Toprak, Tolga Ozcan, Kasım Ertas, Onder Canguven, Fatih Tarhan. Comparison of the safety and efficacy of the on‐demand use of sertraline, dapoxetine, and daily use of sertraline in the treatment of patients with lifelong premature ejaculation: A prospective randomised study. Andrologia 2020; 52(11) doi: 10.1111/and.13854
|
| 6 |
Ya Feng, Lu Hang, Yan Zhou, Feng-Ru Jiang, Jian-Ye Yuan. Gut microbiota plays a role in irritable bowel syndrome by regulating 5-HT metabolism. World Chinese Journal of Digestology 2022; 30(21) doi: 10.11569/wcjd.v30.i21.941
Abstract(979) |
Core Tip(796) |
Full Article(HTML)(5479)
|
Times Cited (0)
|
Total Visits (5846)
|
Open
|
| 7 |
Seung Yong Shin, Ju Yup Lee, Sung Won Jung, Seung-Ho Jang, Han Seung Ryu, Ayoung Lee, Geun Tae Park, Woongki Chang, Minkyong Kim, Beom Seuk Hwang, Yong Sung Kim, Joong Goo Kwon. Clinicians’ Knowledge, Attitudes, and Practices Regarding the Management of Functional Gastrointestinal Disorders With Neuromodulators and Psychological Treatment. Journal of Neurogastroenterology and Motility 2024; 30(4) doi: 10.5056/jnm23161
|
| 8 |
Mustafa Abdul Karim, Nadeen Al-Baz, Peter M. Haddad, Shuja M. Reagu, Majid Alabdulla. Buspirone in the management of refractory irritable bowel syndrome. Medicine 2021; 100(51) doi: 10.1097/MD.0000000000028003
|
| 9 |
Sepideh Hajivand, Mohammadreza Sharifi, Ardeshir Talebi, Maedeh Ghasemi. β‐Sitosterol Restored Intestinal Barrier Integrity and Reduced Intestinal Hypermotility in Stress‐Induced IBS: Comparison With Sertraline. Journal of Biochemical and Molecular Toxicology 2026; 40(5) doi: 10.1002/jbt.70789
|
| 10 |
Fatima Soufan, Abir Ghosson, Rayyan Jaber, Adel Ghandour, Olivier Uwishema. The Gut‐Brain Axis in Irritable Bowel Syndrome: Implementing the Role of Microbiota and Neuroimmune Interaction in Personalized Prevention—A Narrative Review. Health Science Reports 2025; 8(4) doi: 10.1002/hsr2.70660
|
| 11 |
Alexander J Kaye, Shivani J Patel, Sarah R Meyers, Pooja Saiganesh, Sushil Ahlawat. Outcomes of Patients Hospitalized for Acute Diverticulitis With Comorbid Generalized Anxiety Disorder. Cureus 2023; doi: 10.7759/cureus.35461
|
| 12 |
Zhiyong Wang. Oral paroxetine improves symptoms and quality of life in refractory irritable bowel syndrome: a retrospective study. American Journal of Translational Research 2025; 17(11) doi: 10.62347/BQWP2309
|
| 13 |
Mónica Gros, Belén Gros, José Emilio Mesonero, Eva Latorre. Neurotransmitter Dysfunction in Irritable Bowel Syndrome: Emerging Approaches for Management. Journal of Clinical Medicine 2021; 10(15) doi: 10.3390/jcm10153429
|
| 14 |
Nayoung Kwak, Hankil Lee, Beom Kyung Kim, Yun Mi Yu, Hye‐Young Kang. Association between selective serotonin reuptake inhibitor use and developing irritable bowel syndrome through retrospective analysis. Journal of Gastroenterology and Hepatology 2024; 39(2) doi: 10.1111/jgh.16406
|
| 15 |
Rosa Lu Yu, H. Christian Weber. Irritable bowel syndrome, the gut microbiome, and diet. Current Opinion in Endocrinology, Diabetes & Obesity 2025; 32(3) doi: 10.1097/MED.0000000000000905
|
| 16 |
Francis Creed. Review article: the incidence and risk factors for irritable bowel syndrome in population‐based studies. Alimentary Pharmacology & Therapeutics 2019; 50(5) doi: 10.1111/apt.15396
|